Russell Frank Company’s Kite Pharma, Inc. KITE Stock Holding History

Russell Frank Company’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$479K	Buy	10,439 +1,030	+11%	+$49.9K	﹤0.01%	2467
2015 Q4	$589K	Buy	9,409 +2,839	+43%	+$200K	﹤0.01%	2437
2015 Q3	$366K	Buy	6,570 +225	+4%	+$14.2K	﹤0.01%	2568
2015 Q2	$387K	Buy	6,345 +1,345	+27%	+$76.7K	﹤0.01%	2655
2015 Q1	$288K	Buy	+5,000	New	+$335K	﹤0.01%	2546

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's KITE Position: Q1 2016 in Review

Russell Frank Company increased its Kite Pharma, Inc. (KITE) stake by 11% in Q1 2016, buying an estimated $49.9K and bringing the position to 10,439 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Russell Frank Company first reported a position in KITE in Q1 2015 and has held it in 5 quarters since. The position peaked at $589K in Q4 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Russell Frank Company held 10,439 shares of Kite Pharma, Inc. worth $479K as of Q1 2016.
Russell Frank Company bought 1,030 Kite Pharma, Inc. shares in Q1 2016, an estimated $49.9K.
Kite Pharma, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2467 holding.
Russell Frank Company first reported a position in Kite Pharma, Inc. in Q1 2015 and has held it in 5 quarters since.
Russell Frank Company's Kite Pharma, Inc. position peaked at $589K in Q4 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.